The SHARON trial is ongoing and will be expanding to include patients without a BRCA or PALB2 mutation, and General Oncology plans to continue evaluating outcomes and long-term follow-up in this ...

Abstract: The terahertz (THz) waves have broad application prospects in communication, imaging, detection, and other fields. Achieving arbitrary control of THz waves is key to advancing THz technology ...

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopeniaRecommendation based on LUNA 3 phase 3 study ...

A team from the Faculty of Physics and the Center for Quantum Optical Technologies at the University of Warsaw has developed ...

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

Multivariate analyses segmented the aging process into four stages, revealing trends in aroma changes and highlighting key aroma-active compounds. Researchers utilized HS-SPME-GC-MS combined with ...

Churchill Capital Corp X (NASDAQ:CCCX) shares are trading higher Thursday after Infleqtion announced a partnership with ...

In addition to radar sensing capabilities, this IR-UWB transceiver offers another feature that sets it apart from existing ...

Arvinas has announced positive biomarker, pharmacokinetic and pharmacodynamic data from two Phase I studies assessing ARV-102 ...

The new motor driver supports both sensor-based and sensorless control while aiding configuration with programmable flash.

BOSTON, Sept. 17, 2025 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today ...